Patents by Inventor Peilong LU

Peilong LU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250178933
    Abstract: Provided are methods for recovering calcium carbonate (CaCO3) and magnesium hydroxide (Mg(OH)2) from an aqueous solution containing Ca2+ and Mg2+ ions. The method includes: introducing the aqueous solution into an electrochemical cell having a chamber with a photoactive cathode and an anode therein; and then performing process (a) and process (b). Process (a) entails introducing a source of (bi) carbonate anion into the cell, providing a voltage across the cell, resulting in a process (a) water reduction reaction at the cathode, and precipitating solid CaCO3 from the solution, facilitated by hydroxide ions generated from the process (a) water reduction reaction. Process (b) entails providing a voltage across the cell, resulting in a process (b) water reduction reaction at the cathode, and precipitating solid Mg(OH)2 from the solution, facilitated by hydroxide ions generated from the process (b) water reduction reaction.
    Type: Application
    Filed: March 10, 2023
    Publication date: June 5, 2025
    Applicant: Cornell University
    Inventors: Greeshma GADIKOTA, Peilong LU
  • Publication number: 20230192773
    Abstract: Disclosed herein are polypeptide comprising an amino acid sequence at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% identical to the amino acid sequence of any one of SEQ ID NOS: 1-4, oligomers thereof, and uses thereof.
    Type: Application
    Filed: April 28, 2021
    Publication date: June 22, 2023
    Inventors: Chunfu XU, Peilong LU, Tamer GAMAL EL-DIN, William A. CATTERALL, David BAKER
  • Publication number: 20210363214
    Abstract: De novo designed multi-pass transmembrane polypeptides are described, that include 2 or more transmembrane domains that are each between 15 and 35 amino acids in length, include one or more polar residues, and include at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, or more hydrophobic amino acid residues.
    Type: Application
    Filed: February 28, 2019
    Publication date: November 25, 2021
    Inventors: Peilong LU, David BAKER, Scott BOYKEN, Zibo CHEN, Jorge FALLAS, George UEDA, William H. SHEFFLER